table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Liver Diseases Therapeutics Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Liver Diseases Therapeutics Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Liver Diseases Therapeutics Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Liver Diseases Therapeutics Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Liver Diseases Therapeutics Drugs Industry Impact
Chapter 2 Global Liver Diseases Therapeutics Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Liver Diseases Therapeutics Drugs (Volume and Value) by Type
2.1.1 Global Liver Diseases Therapeutics Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Liver Diseases Therapeutics Drugs (Volume and Value) by Application
2.2.1 Global Liver Diseases Therapeutics Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Liver Diseases Therapeutics Drugs (Volume and Value) by Regions
2.3.1 Global Liver Diseases Therapeutics Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Liver Diseases Therapeutics Drugs Consumption by Regions (2016-2021)
4.2 North America Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Liver Diseases Therapeutics Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Liver Diseases Therapeutics Drugs Market Analysis
5.1 North America Liver Diseases Therapeutics Drugs Consumption and Value Analysis
5.1.1 North America Liver Diseases Therapeutics Drugs Market Under COVID-19
5.2 North America Liver Diseases Therapeutics Drugs Consumption Volume by Types
5.3 North America Liver Diseases Therapeutics Drugs Consumption Structure by Application
5.4 North America Liver Diseases Therapeutics Drugs Consumption by Top Countries
5.4.1 United States Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Liver Diseases Therapeutics Drugs Market Analysis
6.1 East Asia Liver Diseases Therapeutics Drugs Consumption and Value Analysis
6.1.1 East Asia Liver Diseases Therapeutics Drugs Market Under COVID-19
6.2 East Asia Liver Diseases Therapeutics Drugs Consumption Volume by Types
6.3 East Asia Liver Diseases Therapeutics Drugs Consumption Structure by Application
6.4 East Asia Liver Diseases Therapeutics Drugs Consumption by Top Countries
6.4.1 China Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Liver Diseases Therapeutics Drugs Market Analysis
7.1 Europe Liver Diseases Therapeutics Drugs Consumption and Value Analysis
7.1.1 Europe Liver Diseases Therapeutics Drugs Market Under COVID-19
7.2 Europe Liver Diseases Therapeutics Drugs Consumption Volume by Types
7.3 Europe Liver Diseases Therapeutics Drugs Consumption Structure by Application
7.4 Europe Liver Diseases Therapeutics Drugs Consumption by Top Countries
7.4.1 Germany Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.3 France Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Liver Diseases Therapeutics Drugs Market Analysis
8.1 South Asia Liver Diseases Therapeutics Drugs Consumption and Value Analysis
8.1.1 South Asia Liver Diseases Therapeutics Drugs Market Under COVID-19
8.2 South Asia Liver Diseases Therapeutics Drugs Consumption Volume by Types
8.3 South Asia Liver Diseases Therapeutics Drugs Consumption Structure by Application
8.4 South Asia Liver Diseases Therapeutics Drugs Consumption by Top Countries
8.4.1 India Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Liver Diseases Therapeutics Drugs Market Analysis
9.1 Southeast Asia Liver Diseases Therapeutics Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Liver Diseases Therapeutics Drugs Market Under COVID-19
9.2 Southeast Asia Liver Diseases Therapeutics Drugs Consumption Volume by Types
9.3 Southeast Asia Liver Diseases Therapeutics Drugs Consumption Structure by Application
9.4 Southeast Asia Liver Diseases Therapeutics Drugs Consumption by Top Countries
9.4.1 Indonesia Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Liver Diseases Therapeutics Drugs Market Analysis
10.1 Middle East Liver Diseases Therapeutics Drugs Consumption and Value Analysis
10.1.1 Middle East Liver Diseases Therapeutics Drugs Market Under COVID-19
10.2 Middle East Liver Diseases Therapeutics Drugs Consumption Volume by Types
10.3 Middle East Liver Diseases Therapeutics Drugs Consumption Structure by Application
10.4 Middle East Liver Diseases Therapeutics Drugs Consumption by Top Countries
10.4.1 Turkey Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Liver Diseases Therapeutics Drugs Market Analysis
11.1 Africa Liver Diseases Therapeutics Drugs Consumption and Value Analysis
11.1.1 Africa Liver Diseases Therapeutics Drugs Market Under COVID-19
11.2 Africa Liver Diseases Therapeutics Drugs Consumption Volume by Types
11.3 Africa Liver Diseases Therapeutics Drugs Consumption Structure by Application
11.4 Africa Liver Diseases Therapeutics Drugs Consumption by Top Countries
11.4.1 Nigeria Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Liver Diseases Therapeutics Drugs Market Analysis
12.1 Oceania Liver Diseases Therapeutics Drugs Consumption and Value Analysis
12.2 Oceania Liver Diseases Therapeutics Drugs Consumption Volume by Types
12.3 Oceania Liver Diseases Therapeutics Drugs Consumption Structure by Application
12.4 Oceania Liver Diseases Therapeutics Drugs Consumption by Top Countries
12.4.1 Australia Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Liver Diseases Therapeutics Drugs Market Analysis
13.1 South America Liver Diseases Therapeutics Drugs Consumption and Value Analysis
13.1.1 South America Liver Diseases Therapeutics Drugs Market Under COVID-19
13.2 South America Liver Diseases Therapeutics Drugs Consumption Volume by Types
13.3 South America Liver Diseases Therapeutics Drugs Consumption Structure by Application
13.4 South America Liver Diseases Therapeutics Drugs Consumption Volume by Major Countries
13.4.1 Brazil Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Liver Diseases Therapeutics Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Liver Diseases Therapeutics Drugs Business
14.1 F. Hoffmann-La Roche
14.1.1 F. Hoffmann-La Roche Company Profile
14.1.2 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Specification
14.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Gilead Sciences
14.2.1 Gilead Sciences Company Profile
14.2.2 Gilead Sciences Liver Diseases Therapeutics Drugs Product Specification
14.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GlaxoSmithKline
14.3.1 GlaxoSmithKline Company Profile
14.3.2 GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Specification
14.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Johnson & Johnson
14.4.1 Johnson & Johnson Company Profile
14.4.2 Johnson & Johnson Liver Diseases Therapeutics Drugs Product Specification
14.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Merck
14.5.1 Merck Company Profile
14.5.2 Merck Liver Diseases Therapeutics Drugs Product Specification
14.5.3 Merck Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Achillion Pharmaceuticals
14.6.1 Achillion Pharmaceuticals Company Profile
14.6.2 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Specification
14.6.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 AbbVie
14.7.1 AbbVie Company Profile
14.7.2 AbbVie Liver Diseases Therapeutics Drugs Product Specification
14.7.3 AbbVie Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Angion Biomedica
14.8.1 Angion Biomedica Company Profile
14.8.2 Angion Biomedica Liver Diseases Therapeutics Drugs Product Specification
14.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Bayer
14.9.1 Bayer Company Profile
14.9.2 Bayer Liver Diseases Therapeutics Drugs Product Specification
14.9.3 Bayer Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 LG Life Sciences
14.10.1 LG Life Sciences Company Profile
14.10.2 LG Life Sciences Liver Diseases Therapeutics Drugs Product Specification
14.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Phenex Pharmaceuticals
14.11.1 Phenex Pharmaceuticals Company Profile
14.11.2 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Specification
14.11.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 ProMetic Life Sciences
14.12.1 ProMetic Life Sciences Company Profile
14.12.2 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Specification
14.12.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Raptor Pharmaceuticals
14.13.1 Raptor Pharmaceuticals Company Profile
14.13.2 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Specification
14.13.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Shenzhen Kangtai Biological Products
14.14.1 Shenzhen Kangtai Biological Products Company Profile
14.14.2 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Specification
14.14.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Verva Pharmaceuticals
14.15.1 Verva Pharmaceuticals Company Profile
14.15.2 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Specification
14.15.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Liver Diseases Therapeutics Drugs Market Forecast (2022-2027)
15.1 Global Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Liver Diseases Therapeutics Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Liver Diseases Therapeutics Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Liver Diseases Therapeutics Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Liver Diseases Therapeutics Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Liver Diseases Therapeutics Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Liver Diseases Therapeutics Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Liver Diseases Therapeutics Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Liver Diseases Therapeutics Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Liver Diseases Therapeutics Drugs Price Forecast by Type (2022-2027)
15.4 Global Liver Diseases Therapeutics Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Liver Diseases Therapeutics Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
